OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid · OpenFeds · OpenSpending

© 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodology•Download Data
  1. Home
  2. Procedures
  3. Q5128
  4. Cost Analysis

How Much Does Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg Cost on Medicare?

Cost analysis for CPT Q5128 — Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg

Share:

Average Medicare Payment

$216.45

2023 data

Total Payments (2023)

$95.8M

Services (2023)

442.2K

Price Change (2023–2023)

0.0%

📈 Year-over-Year Cost Trend

YearAvg PaymentTotal PaymentsServicesYoY Change
2023$216.45$95.8M442.2K—

🗺️ State-by-State Cost Variation

The most expensive state pays 1.1x more than the cheapest for this procedure. IN averages $236.66 vs MD at $213.30.

StateAvg PaymentTotal PaymentsServicesProviders
IN$236.66$1.2M5.2K7
KS$221.02$250.4K1.1K3
UT$219.98$276.3K1.3K4
CA$218.05$14.3M65.7K50
OR$217.69$126.3K5802
LA$217.26$249.0K1.1K2
MN$217.05$6.7M30.8K17
TX$217.01$14.2M65.6K54
GA$216.91$295.9K1.4K3
FL$216.86$8.9M40.9K41
SC$216.56$3.8M17.7K14
ID$216.54$108.5K5011
WA$216.48$1.8M8.2K13
OK$216.36$728.9K3.4K4
NY$216.33$5.4M24.8K20
CO$216.27$837.0K3.9K11
PA$216.19$18.5M85.3K22
CT$216.12$525.8K2.4K5
NC$216.08$334.5K1.5K4
AZ$215.97$3.3M15.4K16
NV$215.47$95.0K4411
VA$215.44$565.5K2.6K8
MO$215.38$460.1K2.1K3
AL$215.32$1.3M6.0K2
OH$215.09$49.5K2301
MI$215.03$148.2K6893
MS$214.92$349.2K1.6K4
NJ$214.80$2.1M9.7K15
MA$214.66$143.8K6702
HI$214.64$80.3K3741
TN$214.52$6.7M31.2K17
IL$214.30$566.8K2.6K4
MD$213.30$1.5M6.9K19

💰 Who Bills the Most for This Procedure?

ProviderSpecialtyStatePaymentsServicesAvg/Service
Omesh GuptaOphthalmologyPA$1.8M8.4K$216.15
David WilliamsOphthalmologyMN$1.7M8.0K$217.48
Richard KaiserOphthalmologyPA$1.7M8.0K$216.42
Homayoun TabandehOphthalmologyCA$1.6M7.4K$219.39
Stephen CouvillionOphthalmologyCA$1.5M7.1K$219.00
Yoshihiro YonekawaOphthalmologyPA$1.4M6.3K$215.94
Mitchell FinemanOphthalmologyPA$1.4M6.3K$216.55
Nathan SteinleOphthalmologyCA$1.3M6.0K$217.23
Marc SpirnOphthalmologyPA$1.3M6.0K$216.51
James VanderOphthalmologyPA$1.3M6.0K$216.64
Peter NixonOphthalmologyTX$1.1M4.9K$216.90
Carl RegilloOphthalmologyPA$1.1M4.9K$215.52
Sunir GargOphthalmologyPA$1.0M4.8K$216.55
Brandon BusbeeOphthalmologyTN$1.0M4.8K$212.88
Alessandro CastellarinOphthalmologyCA$1.0M4.6K$218.33
Sunil PatelOphthalmologyTX$973.8K4.5K$218.15
Abdhish BhavsarOphthalmologyMN$963.8K4.4K$217.32
Jonathan JonischOphthalmologyNY$934.3K4.3K$216.12
Duo XuOphthalmologyPA$914.6K4.2K$215.65
Allen ChiangOphthalmologyPA$885.5K4.1K$216.60

🤔 Is Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg Overpriced?

Based on the data, CPT Q5128 shows a 1.1x variation in pricing across states — relatively consistent by Medicare standards.

Costs have decreased 0% since 2023. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.

This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.

Data Sources

  • • Centers for Medicare & Medicaid Services (CMS)
  • • Medicare Provider Utilization and Payment Data (2014-2023)
  • • Medicare Physician Fee Schedule

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.